氩氦刀冷冻术联合中药治疗57例非小细胞肺癌的临床观察
Clinical observation on the combined treatment of 57 cases of non-small cell lung cancer using argon-helium cryosurgery and Chinese herbal medicine.
作者信息
Hu Kai-wen, Li Quan-wang, Zuo Ming-huan, Sun Tao, Jiang Min
机构信息
Tumor Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China.
出版信息
Chin J Integr Med. 2007 Sep;13(3):224-7. doi: 10.1007/s11655-007-0224-4.
OBJECTIVE
To observe the clinical effect of the combined therapy using argon-helium cryosurgery (Ar-He knife) and Chinese herbal medicine in treating non-small cell lung cancer (NSCLC).
METHODS
Fifty-seven patients of NSCLC were treated with the combined therapy and observed.
RESULTS
The treatment was successfully completed in all patients with mild adverse reactions. The effective rate was 83.8% 3 months after the operation, 79.6% 6 months after the operation, and 77.3% 12 months after the operation, with median survival of 9 months. The survival rate after 12 months was 46.67% (21/45), 34.62% (9/26) after 18 months, and 36.36% (4/11) after 24 months.
CONCLUSION
Argon-helium cryosurgery therapy is superior in its assured orientation, quick tumor load deprivation and less postoperational reaction. Combined with Chinese herbal medication, Argon-helium cryosurgery therapy can prolong survival time, relieve clinical symptoms, and elevate the quality of life in NSCLC patients, and is thus worthy of promotion.
目的
观察氩氦刀冷冻手术联合中药治疗非小细胞肺癌（NSCLC）的临床疗效。
方法
对57例NSCLC患者采用联合疗法进行治疗并观察。
结果
所有患者均顺利完成治疗，不良反应轻微。术后3个月有效率为83.8%，术后6个月为79.6%，术后12个月为77.3%，中位生存期为9个月。12个月生存率为46.67%（21/45），18个月为34.62%（9/26），24个月为36.36%（4/11）。
结论
氩氦刀冷冻手术治疗定位准确、能快速减轻肿瘤负荷且术后反应较小。联合中药治疗可延长NSCLC患者的生存时间，缓解临床症状，提高生活质量，值得推广。
Zotero 插件